Category Archives: Business of Biotech

Synthetic Biology Products: Cost Competitive and Performance Driven

science lab technician

The Monday morning BIO World Congress session, commanded an overcrowded and enthusiastic attendance, and one of the few times where presentations involved the importance of synthetic biology technology for the production of consumer products, which drew more attention than ever before. The session was kicked off by the CEO of Modular Genetics, Kevin Jarrell, who spoke about the production of glycinate an ultra-mild surfactant made by using engineered microorganism which converted underutilized agricultural waste material into useful renewable chemicals found Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , ,

Algae and cow cells: BIO members using plants, animals in new ways

Algae oil into fuel

Sara Wyant, Editor/Publisher at Agri-Pulse Communications, Inc. attended the 2015 BIO World Congress on Industrial Biotechnology and wrote a great piece highlighting the conference: * * * Algae and leaf-based oils for food and fuel, meat without slaughter, and healthy sugar are all part of the not-so-distant future envisioned at the Biotechnology Industry Organization’s (BIO’s) World Congress in Montreal this week. “Our world needs what we in this room are doing,” Jonathan Wolfson, CEO of Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

BIO World Congress GreenTech Investor Sessions

BIO World Congress

On Monday, July 20, the GreenTech Investor Sessions took place at the at the BIO World Congress. Eleven companies made formal, 15-minute presentations on their technology development and business models to an audience of elite investors, analysts, and conference attendees. These companies were chosen to present by an external advisory panel of investors following an application and selection process. The top eleven companies included: Forelight has developed a patented photosynthetic growth platform that provides highly Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , ,

Biotech Companies Find Solutions through Synthetic Biology

scientist, lab

Several small companies presented their business models and milestones in the New and Innovative Technological Advances breakout session during the opening day of BIO’s World Congress. Each of the companies started out seeking an alternative to petroleum as a raw material for plastics and other polymers used in everyday household products. Additionally, these companies were united in finding unique solutions to scientific challenges through synthetic biology approaches. Eric Althoff, CBO of ten-year-old Arzeda, described his Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Riding the Bull Market: What’s in Store for Biotech Dealmakers in 2015?

72263479

In many ways, 2014 was a record year for biopharma dealmaking, with $355 billion in total transactions, including $53 billion in partnering deals, $16.5 billion in venture investments and 133 IPOs. According to the 2015 Campbell Alliance Dealmakers’ Intentions Study, 2015 is shaping up to be the year of historic M&A in the biopharmaceutical sector, driven in part by greater access to capital. The partnering numbers at BIO 2015 further indicate that the appetite for Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,